Outcome of Primary Mediastinal Large B Cell Lymphoma Treated with RCHOP.

Khalid Halahleh,Abeer Yaseen,Isra Muradi,Akram Al-Ibraheem,Iyad Sultan,Mohammad Ma'koseh

Journal of blood medicine（2023）

引用 0|浏览2

暂无评分

摘要

In PMLBCL, RCHOP chemotherapy backbone in the frontline therapy is suboptimal but can be used in patients with low IPI. Adapting more intensive chemoimmunotherapy regimens may be considered for patients with high IPI. Salvage chemotherapy has limited activity in patients with relapsed or refractory disease.

查看译文

关键词

end of treatment response,international prognostic index,radiotherapy,salvage chemotherapy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要